Prevalence Estimates

The Vision and Eye Health Surveillance System (VEHSS) creates composite estimates of vision loss and major eye disease prevalence at the national, state, and county level by integrating many of the data sources featured in VEHSS, including published examination studies, national surveys, and administrative claims data.

Prevalence of Vision Loss

Vision Loss Prevalence Estimates at a Glance

NHANES at a Glance
Data Type Predicted prevalence rates and prevalence counts created using a statistical modeling approach
Source Data
  • National Health and Nutrition Examination Survey (NHANES), best corrected acuity (reference point data source)
  • Review of published examination studies
  • American Community Survey (ACS) household self-reported blind or difficulty seeing with glasses, used for variation of vision loss by state, among children, and among people living in group quarters including nursing homes and prison. Source for 2017 population estimates by county.
  • National Survey of Children’s Health (NSCH) household self-reported blind or difficulty seeing used for variation in vision loss among children by demographics and state.
Case Definition Best-corrected visual acuity in the better seeing-eye
Vision Loss: ≤20/40
Blindness: ≤20/200
Year Released 2021, estimates based on 2017 population estimates.
Publication Prevalence of visual acuity loss or blindness in the USexternal icon
Suggested citation Flaxman AD, Wittenborn JS, Robalik T, Gulia R, Gerzoff RB, Lundeen EA, Saaddine J, Rein DB. Prevalence of visual acuity loss or blindness in the USexternal icon. JAMA Ophthalmology. 2021;in press


The VEHSS Composite Prevalence Estimate of Vision Loss is CDC’s primary estimate of vision loss prevalence.  VEHSS researchers used a statistical methodology called Bayesian meta-regression to combine information from multiple data sources available in VEHSS to produce vision loss and blindness prevalence estimates among the entire US population in 2017.  The estimates are standardized to the national age, gender, and race/ethnicity distribution.

Case Definition:

Vision loss is defined as permanent or uncorrectable vision loss based on the best-corrected visual acuity (BCVA) in the better-seeing eye, as measured using the methodology of the National Health and Nutrition Examination Survey (NHANES).  These estimates measure the best visual function obtainable with proper glasses or contact lenses. These estimates do not include vision loss due to inadequate corrective glasses or contacts (uncorrected refractive error). They also do not capture impairment caused only by visual field or contrast sensitivity problems.

  • Vision Loss: best corrected visual acuity 20/40 or worse.
  • Blindness: best corrected visual acuity 20/200 or worse.
Highlighted Results

Overall Findings

  • In 2017, 7.08 million Americans had some form of vision loss or blindness.
  • Approximately 6 million Americans have vision loss and 1.08 million are blind.
  • More than 1.6 million Americans who are living with vision loss or blindness are younger than age 40.
  • 358,000 people with vision loss or blindness are living in group quarters, such as nursing homes or prisons.
  • 20% of all people older than 85 years experience permanent vision loss.
  • More females than males experience permanent vision loss or blindness.
  • There is a higher risk of vision loss among Hispanic/Latino and Black individuals than among White individuals.
  • The prevalence of vision loss varies by state, ranging from 1.3% in Maine to 3.6% in West Virginia.

National Results:

Table 1. Prevalence of Vision Loss and Blindness, Number of People (95% uncertainty interval)

Overview of NHANES Self-Report Variables Included in VEHSS
Vision Loss
(20/40 or worse)
(20/200 or worse)
Overall National 7,078,735 (6,322,754-7,889,855) 1,083,372 (820,259-1,296,205)
Female 4,158,921 (3,622,359-4,690,174) 635,102 (478,628-794,623)
Male 2,919,814 (2,525,697-3,368,931) 344,500 (231,704-457,339)
Black (Non-hispanic) 1,023,624 (871,220-1,180,706) 167,194 (127,445-213,167)
Hispanic 1,264,765 (1,074,402-1,471,611) 124,002 (93,333-158,539)
White (Non-hispanic) 4,271,190 (3,677,379-4,871,864) 737,558 (557,225-922,499)
Other Race 519,155 (411,143-624,722) 54,618 (37,773-76,731)
0-17 Years 602,287 (401,777-831,576) 43,108 (23,623-64,794)
18-39 Years 1,017,271 (867,652-1,192,641) 98,038 (70,619-133,103)
40-64 Years 1,267,439 (1,084,188-1,472,835) 147,432 (110,677-192,000)
65-84 Years 2,892,574 (2,484,907-3,424,150) 450,294 (348,818-562,242)
85+ Years 1,299,164 (1,109,847-1,458,287) 344,500 (231,704-457,339)

Figure 1. Prevalence Rate (Percentage of US Resident Population) with Vision Loss or Blindness, by Age Group (in years)

Figure 2. Prevalence Rate (Percentage of US Resident Population) with Vision Loss or Blindness, by Sex and Race

Data described in downloadable excel file below

Download the data for Figure 2 [XLS – 9 KB]

Figure 3. Prevalence Rate (Percentage of US Resident Population) with Vision Loss, by County

Data available in excel document link below map

Download the data for figure 3  [XLS – 365 KB]


The VEHSS prevalence estimates of vision loss and blindness were estimated using a statistical modeling approach called Bayesian meta-regression, which researchers used to combine information from multiple VEHSS data sources into a single summary estimate. The VEHSS estimates use measured visual acuity data from National Health and Nutrition Examination Survey (NHANES) as the reference point dataset to create output based on the characteristics and performance of the NHANES vision exam. In addition to NHANES, the estimation model used population-based study data to provide additional evidence, and self-reported survey data to provide information on variation by state, county and among under-represented population groups.

Full details of the methods are available in the publication and online appendix Flaxman et al 2021external icon.

More Visual Function Indicators in the VEHSS Data Explorer

CDC uses the VEHSS composite estimate as the primary estimate to assess the percentage of people with uncorrectable vision impairment and blindness in the United States by state, county, and across different age groups, race/ethnicity categories, and sex. However, VEHSS also contains several other data sources with prevalence or useful information about vision loss and blindness. Readers should consider all sources when deciding which to use to fit their specific information needs.

Self-Report Measures: VEHSS contains estimates of individuals who reported difficulties with their vision during their survey responses to the ACS, Behavioral Risk Factor Surveillance System (BRFSS), National Health Interview Survey (NHIS), and the National Survey of Children’s Health (NSCH). These estimates represent people with both correctable and uncorrectable vision problems. Estimates from these sources are sensitive to question wording and the data collection mode (Rein et al. Vision Impairment and Blindness Prevalence in the United States: Variability of Vision Health Responses across Multiple National Surveysexternal icon).  The VEHSS vision loss prevalence estimates use two sources of survey self-reported information (ACS and NSCH) to estimate variations in vision loss and blindness geographically (ACS) and among children (NSCH).

Measured Acuity: VEHSS contains national prevalence estimates of measured, correctable and uncorrectable visual acuity deficits from NHANES. The VEHSS vision loss prevalence estimate uses this information and population-based study data to estimate the total number of people with vision loss and blindness in 2017. The original NHANES estimates are available on the VEHSS Data Explorer but are only available at the national level and were last collected in 2008.

The VEHSS Data Explorer also contains information on patients with measured vision impairment or blindness as measured by ophthalmologists and reported to the IRIS Registry©. The IRIS Registry© data can be used to look at state and population differences but are only applicable to people who visited an ophthalmologist and participated in the IRIS Registry©. Finally, the VEHSS Data Explorer contains a review of selected published vision examination studies. Published results from some of these studies were used to create the VEHSS vision loss prevalence estimate.

Utilization Measures: The VEHSS Data Explorer contains information on using health services related to vision problems as coded in insurance claims information obtained from Medicare, Medicaid, commercial medical insurance (MarketScan), and managed vision care (VSP) programs, as well as services included in ophthalmology electronic health records summarized by the IRIS Registry©. These estimates measure the proportion of patients who received at least one medical service coded with a diagnosis code for vision impairment or blindness. These measures can be used to assess the proportion of people who received services for diagnosed vision problems.


Using the VEHSS Composite Estimates of Vision Loss is CDC’s best way to estimate the percentage of US residents that have vision loss and blindness, where they live, and who they are. These estimates are based on uncorrectable visual acuity loss, and therefore represent permanent vision loss that cannot be corrected with glasses. These differ from survey self-report measures, which represents self-assessed visual function, presents acuity loss included in NHANES, and measures visual acuity based on a persons’ current use of glasses or contacts.

Users should consider these differences in measures when deciding if the composite estimates of vision loss, survey self-report, or other data sources are most appropriate to answer their research question when considering which source best matches their objectives.

Prevalence of Age-related Macular Degeneration

In progress

Prevalence of Diabetic Retinopathy

In progress

Prevalence of Glaucoma

In progress